

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tyrosine metabolic process (GO:0006570) | 8.46564749 |
| 2 | hemidesmosome assembly (GO:0031581) | 8.09587750 |
| 3 | ketone body metabolic process (GO:1902224) | 6.15088753 |
| 4 | cell adhesion mediated by integrin (GO:0033627) | 5.97296094 |
| 5 | desmosome organization (GO:0002934) | 5.63269039 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.08664957 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.08664957 |
| 8 | aromatic amino acid family metabolic process (GO:0009072) | 4.94860276 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.92799219 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.92799219 |
| 11 | membrane raft organization (GO:0031579) | 4.82227790 |
| 12 | secondary metabolic process (GO:0019748) | 4.67705539 |
| 13 | skin morphogenesis (GO:0043589) | 4.66568634 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 4.62865522 |
| 15 | cell-substrate junction assembly (GO:0007044) | 4.57262071 |
| 16 | cysteine metabolic process (GO:0006534) | 4.54648359 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 4.46946431 |
| 18 | Golgi transport vesicle coating (GO:0048200) | 4.46946431 |
| 19 | short-chain fatty acid metabolic process (GO:0046459) | 4.44728387 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.35450665 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.29836660 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.27895206 |
| 23 | protein carboxylation (GO:0018214) | 4.26988178 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.26988178 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.25633400 |
| 26 | tryptophan catabolic process (GO:0006569) | 4.21077031 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.21077031 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.21077031 |
| 29 | urea cycle (GO:0000050) | 4.20200036 |
| 30 | urea metabolic process (GO:0019627) | 4.20200036 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 4.19514560 |
| 32 | nuclear pore complex assembly (GO:0051292) | 4.19054609 |
| 33 | phenol-containing compound biosynthetic process (GO:0046189) | 4.17733708 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 4.10334475 |
| 35 | mesodermal cell differentiation (GO:0048333) | 4.09218003 |
| 36 | cellular glucuronidation (GO:0052695) | 4.08046488 |
| 37 | lysine catabolic process (GO:0006554) | 4.06413520 |
| 38 | lysine metabolic process (GO:0006553) | 4.06413520 |
| 39 | bile acid biosynthetic process (GO:0006699) | 4.04849792 |
| 40 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.98131254 |
| 41 | protein localization to endosome (GO:0036010) | 3.96853158 |
| 42 | homocysteine metabolic process (GO:0050667) | 3.96337380 |
| 43 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.95918169 |
| 44 | complement activation, alternative pathway (GO:0006957) | 3.95903797 |
| 45 | regulation of protein activation cascade (GO:2000257) | 3.90888783 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 3.88839575 |
| 47 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.85940992 |
| 48 | glucuronate metabolic process (GO:0019585) | 3.83409730 |
| 49 | uronic acid metabolic process (GO:0006063) | 3.83409730 |
| 50 | negative regulation of fibrinolysis (GO:0051918) | 3.80779015 |
| 51 | keratinocyte proliferation (GO:0043616) | 3.78891346 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.76051602 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.75430761 |
| 54 | regulation of complement activation (GO:0030449) | 3.70738940 |
| 55 | low-density lipoprotein particle clearance (GO:0034383) | 3.68781214 |
| 56 | protein hydroxylation (GO:0018126) | 3.66857500 |
| 57 | positive regulation of osteoblast proliferation (GO:0033690) | 3.66775603 |
| 58 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.59380711 |
| 59 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.59117121 |
| 60 | activation of Rac GTPase activity (GO:0032863) | 3.58192442 |
| 61 | hepatocyte differentiation (GO:0070365) | 3.57893956 |
| 62 | hypotonic response (GO:0006971) | 3.57302750 |
| 63 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56724535 |
| 64 | developmental pigmentation (GO:0048066) | 3.56637093 |
| 65 | regulation of fibrinolysis (GO:0051917) | 3.55735675 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 3.53088416 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.51098359 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 3.50273754 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.46834673 |
| 70 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.42156211 |
| 71 | bile acid metabolic process (GO:0008206) | 3.42150579 |
| 72 | nuclear pore organization (GO:0006999) | 3.40225458 |
| 73 | serine family amino acid catabolic process (GO:0009071) | 3.40117661 |
| 74 | protein retention in ER lumen (GO:0006621) | 3.37838619 |
| 75 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.36476788 |
| 76 | aldehyde catabolic process (GO:0046185) | 3.33334702 |
| 77 | regulation of mitotic spindle organization (GO:0060236) | 3.29212270 |
| 78 | negative regulation of sterol transport (GO:0032372) | 3.29093511 |
| 79 | negative regulation of cholesterol transport (GO:0032375) | 3.29093511 |
| 80 | fibrinolysis (GO:0042730) | 3.28827865 |
| 81 | reverse cholesterol transport (GO:0043691) | 3.26621052 |
| 82 | epithelial cell-cell adhesion (GO:0090136) | 3.25299998 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.24558705 |
| 84 | substrate-dependent cell migration (GO:0006929) | 3.23304544 |
| 85 | macromolecular complex remodeling (GO:0034367) | 3.22046952 |
| 86 | plasma lipoprotein particle remodeling (GO:0034369) | 3.22046952 |
| 87 | protein-lipid complex remodeling (GO:0034368) | 3.22046952 |
| 88 | polyketide metabolic process (GO:0030638) | 3.21453310 |
| 89 | doxorubicin metabolic process (GO:0044598) | 3.21453310 |
| 90 | daunorubicin metabolic process (GO:0044597) | 3.21453310 |
| 91 | urate metabolic process (GO:0046415) | 3.21340215 |
| 92 | valine metabolic process (GO:0006573) | 3.20278830 |
| 93 | triglyceride homeostasis (GO:0070328) | 3.19935723 |
| 94 | acylglycerol homeostasis (GO:0055090) | 3.19935723 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.18808853 |
| 96 | endodermal cell differentiation (GO:0035987) | 3.18740422 |
| 97 | phospholipid efflux (GO:0033700) | 3.17549226 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.14943111 |
| 99 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.13728322 |
| 100 | glutamate metabolic process (GO:0006536) | 3.12937420 |
| 101 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.12767800 |
| 102 | alpha-amino acid catabolic process (GO:1901606) | 3.10594128 |
| 103 | cholesterol efflux (GO:0033344) | 3.10474090 |
| 104 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.10405758 |
| 105 | drug transmembrane transport (GO:0006855) | 3.09230415 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.08006095 |
| 107 | drug catabolic process (GO:0042737) | 3.07852352 |
| 108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.07159005 |
| 109 | indolalkylamine metabolic process (GO:0006586) | 3.07125150 |
| 110 | pore complex assembly (GO:0046931) | 3.05739852 |
| 111 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.05729213 |
| 112 | flavonoid metabolic process (GO:0009812) | 3.04988153 |
| 113 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04819553 |
| 114 | acute-phase response (GO:0006953) | 3.04626758 |
| 115 | mammary gland epithelial cell proliferation (GO:0033598) | 3.04088633 |
| 116 | regulation of metalloenzyme activity (GO:0048552) | 3.01984111 |
| 117 | ethanol oxidation (GO:0006069) | 2.99986465 |
| 118 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.99185072 |
| 119 | 4-hydroxyproline metabolic process (GO:0019471) | 2.98715741 |
| 120 | negative regulation of anoikis (GO:2000811) | 2.97082469 |
| 121 | benzene-containing compound metabolic process (GO:0042537) | 2.96694791 |
| 122 | pigment biosynthetic process (GO:0046148) | 2.96025804 |
| 123 | lipoprotein metabolic process (GO:0042157) | 2.93838660 |
| 124 | bile acid and bile salt transport (GO:0015721) | 2.93769182 |
| 125 | regulation of cholesterol esterification (GO:0010872) | 2.93358110 |
| 126 | cell-substrate adherens junction assembly (GO:0007045) | 2.91669773 |
| 127 | focal adhesion assembly (GO:0048041) | 2.91669773 |
| 128 | serine family amino acid metabolic process (GO:0009069) | 2.91465419 |
| 129 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.91223793 |
| 130 | bone remodeling (GO:0046849) | 2.91223355 |
| 131 | lung vasculature development (GO:0060426) | 2.91001269 |
| 132 | cellular amino acid catabolic process (GO:0009063) | 2.90144259 |
| 133 | coenzyme catabolic process (GO:0009109) | 2.88811495 |
| 134 | surfactant homeostasis (GO:0043129) | 2.88748982 |
| 135 | acetyl-CoA metabolic process (GO:0006084) | 2.88331422 |
| 136 | plasma lipoprotein particle assembly (GO:0034377) | 2.87705933 |
| 137 | cellular response to vitamin D (GO:0071305) | 2.87653898 |
| 138 | sterol homeostasis (GO:0055092) | 2.86641072 |
| 139 | negative regulation of lipase activity (GO:0060192) | 2.86079059 |
| 140 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.85547817 |
| 141 | cholesterol homeostasis (GO:0042632) | 2.85261973 |
| 142 | plasma membrane repair (GO:0001778) | 2.83848794 |
| 143 | positive regulation of blood coagulation (GO:0030194) | 2.83684714 |
| 144 | positive regulation of hemostasis (GO:1900048) | 2.83684714 |
| 145 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.82936616 |
| 146 | glomerular visceral epithelial cell development (GO:0072015) | 2.82916584 |
| 147 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.82863514 |
| 148 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.80840436 |
| 149 | peptidyl-proline hydroxylation (GO:0019511) | 2.80753409 |
| 150 | pigment metabolic process (GO:0042440) | 2.80710537 |
| 151 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.79521076 |
| 152 | adherens junction assembly (GO:0034333) | 2.78261187 |
| 153 | protein localization to microtubule (GO:0035372) | 2.75303094 |
| 154 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.75270264 |
| 155 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.74895438 |
| 156 | mitotic cytokinesis (GO:0000281) | 2.73197519 |
| 157 | cellular protein complex localization (GO:0034629) | 2.72443201 |
| 158 | mitotic chromosome condensation (GO:0007076) | 2.71114986 |
| 159 | gap junction assembly (GO:0016264) | 2.70333506 |
| 160 | COPII vesicle coating (GO:0048208) | 2.69937106 |
| 161 | hippo signaling (GO:0035329) | 2.69050782 |
| 162 | notochord development (GO:0030903) | 2.67113773 |
| 163 | regulation of anoikis (GO:2000209) | 2.65209821 |
| 164 | iron ion import (GO:0097286) | 2.64714307 |
| 165 | diterpenoid biosynthetic process (GO:0016102) | 2.63213518 |
| 166 | glucose catabolic process (GO:0006007) | 2.61891700 |
| 167 | membrane protein ectodomain proteolysis (GO:0006509) | 2.61591317 |
| 168 | ribosome assembly (GO:0042255) | 2.61446040 |
| 169 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.60762381 |
| 170 | pentose-phosphate shunt (GO:0006098) | 2.57245979 |
| 171 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.55014732 |
| 172 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.53909436 |
| 173 | glomerular epithelial cell development (GO:0072310) | 2.49881787 |
| 174 | glucose 6-phosphate metabolic process (GO:0051156) | 2.49817153 |
| 175 | renal filtration (GO:0097205) | 2.46980104 |
| 176 | cellular response to vitamin (GO:0071295) | 2.46690668 |
| 177 | vesicle coating (GO:0006901) | 2.45935871 |
| 178 | regulation of spindle organization (GO:0090224) | 2.45796257 |
| 179 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.45765635 |
| 180 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.44513293 |
| 181 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.44174357 |
| 182 | cell junction assembly (GO:0034329) | 2.43538451 |
| 183 | regulation of translational fidelity (GO:0006450) | 2.41573111 |
| 184 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.40658858 |
| 185 | tight junction assembly (GO:0070830) | 2.40469091 |
| 186 | regulation of hippo signaling (GO:0035330) | 2.39888954 |
| 187 | positive regulation of extracellular matrix organization (GO:1903055) | 2.38755791 |
| 188 | retinal metabolic process (GO:0042574) | 2.36432804 |
| 189 | wound healing, spreading of epidermal cells (GO:0035313) | 2.36161330 |
| 190 | basement membrane organization (GO:0071711) | 2.35747549 |
| 191 | apoptotic cell clearance (GO:0043277) | 2.33948430 |
| 192 | membrane assembly (GO:0071709) | 2.32947638 |
| 193 | negative regulation of fatty acid transport (GO:2000192) | 2.32573177 |
| 194 | receptor catabolic process (GO:0032801) | 2.31185051 |
| 195 | regulation of osteoblast proliferation (GO:0033688) | 2.30883127 |
| 196 | chemical homeostasis within a tissue (GO:0048875) | 2.28986940 |
| 197 | melanin biosynthetic process (GO:0042438) | 12.7204054 |
| 198 | melanin metabolic process (GO:0006582) | 11.4577315 |
| 199 | secondary metabolite biosynthetic process (GO:0044550) | 11.0255115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.11666198 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.98855039 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.18094364 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.81851590 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.47646851 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.41226812 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.62103698 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.33379810 |
| 9 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.24421674 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.14041560 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.07308973 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.06873069 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.96455403 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.81864171 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51337911 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.46049605 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.43528745 |
| 18 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23135630 |
| 19 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22669904 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.18993766 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17919316 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14258327 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.11513138 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01069892 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.96750761 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.94581072 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.83761077 |
| 28 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.81253708 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81252049 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80677821 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74962387 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70240670 |
| 33 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.68022411 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67389114 |
| 35 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.62256986 |
| 36 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.61837518 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57845795 |
| 38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57087272 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56670757 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56114290 |
| 41 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55562290 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51400961 |
| 43 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51258912 |
| 44 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49456319 |
| 45 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.49310561 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48835786 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.46255223 |
| 48 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.42303626 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41297304 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41297304 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40193583 |
| 52 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.38149389 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37655641 |
| 54 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.36035110 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35956458 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35527403 |
| 57 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.34652609 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.32704602 |
| 59 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32325568 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32296271 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31767910 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27734041 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27087206 |
| 64 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24738993 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24687077 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24452019 |
| 67 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.24409122 |
| 68 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24212923 |
| 69 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24212923 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 1.24205456 |
| 71 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23971472 |
| 72 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22748885 |
| 73 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21842213 |
| 74 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21722796 |
| 75 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19012254 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.19000644 |
| 77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.18965673 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17951243 |
| 79 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17899629 |
| 80 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.15689845 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15084548 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14512772 |
| 83 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14248993 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11645093 |
| 85 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09247449 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08614817 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07966779 |
| 88 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.07391160 |
| 89 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05860011 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05801192 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05603795 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05046573 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04474625 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03885198 |
| 95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03815594 |
| 96 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.03207405 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03189370 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03019578 |
| 99 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02516951 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02331830 |
| 101 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.01836959 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01615079 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00893110 |
| 104 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99419865 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98057527 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96882074 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95472560 |
| 108 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94839832 |
| 109 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.94010577 |
| 110 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.91336104 |
| 111 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90743442 |
| 112 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90587000 |
| 113 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89293067 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88070016 |
| 115 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87806661 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87377789 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87103238 |
| 118 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86712391 |
| 119 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86517985 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85715678 |
| 121 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82912277 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82496299 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81779251 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81765515 |
| 125 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80426353 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79571753 |
| 127 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.79229805 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79179759 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77690122 |
| 130 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77207494 |
| 131 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76667633 |
| 132 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76345737 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74502419 |
| 134 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73620966 |
| 135 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.73178157 |
| 136 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.73178157 |
| 137 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.73144186 |
| 138 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72511183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 7.14180191 |
| 2 | MP0005171_absent_coat_pigmentation | 5.47476668 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.08809298 |
| 4 | MP0005408_hypopigmentation | 4.73568871 |
| 5 | MP0005360_urolithiasis | 4.71699427 |
| 6 | MP0004272_abnormal_basement_membrane | 3.74045041 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.71114211 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.39622061 |
| 9 | MP0005365_abnormal_bile_salt | 3.21942971 |
| 10 | MP0000371_diluted_coat_color | 3.19400274 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.94870421 |
| 12 | MP0003136_yellow_coat_color | 2.87898201 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.85790122 |
| 14 | MP0004381_abnormal_hair_follicle | 2.78405605 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.76503873 |
| 16 | MP0003252_abnormal_bile_duct | 2.45653130 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.42493055 |
| 18 | MP0000579_abnormal_nail_morphology | 2.27542372 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.11944517 |
| 20 | MP0010678_abnormal_skin_adnexa | 2.09916446 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.08923817 |
| 22 | MP0005083_abnormal_biliary_tract | 2.08191457 |
| 23 | MP0009840_abnormal_foam_cell | 2.07918701 |
| 24 | MP0000537_abnormal_urethra_morphology | 2.04584152 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.98221376 |
| 26 | MP0003195_calcinosis | 1.98206436 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.93745888 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.91423854 |
| 29 | MP0003941_abnormal_skin_development | 1.89125500 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.89080175 |
| 31 | MP0005248_abnormal_Harderian_gland | 1.88412375 |
| 32 | MP0001324_abnormal_eye_pigmentation | 1.83877546 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.75191681 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.71032639 |
| 35 | MP0004233_abnormal_muscle_weight | 1.71002767 |
| 36 | MP0005332_abnormal_amino_acid | 1.65060158 |
| 37 | MP0005409_darkened_coat_color | 1.64707123 |
| 38 | * MP0000762_abnormal_tongue_morphology | 1.62875390 |
| 39 | MP0001849_ear_inflammation | 1.59485065 |
| 40 | MP0002095_abnormal_skin_pigmentation | 1.59263145 |
| 41 | MP0003878_abnormal_ear_physiology | 1.59026836 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.59026836 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.56645324 |
| 44 | MP0001216_abnormal_epidermal_layer | 1.55306754 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.52862875 |
| 46 | MP0000383_abnormal_hair_follicle | 1.50191498 |
| 47 | MP0005501_abnormal_skin_physiology | 1.47296795 |
| 48 | MP0000467_abnormal_esophagus_morphology | 1.46392527 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.42568695 |
| 50 | MP0002075_abnormal_coat/hair_pigmentati | 1.42051571 |
| 51 | * MP0000609_abnormal_liver_physiology | 1.35165764 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.30590172 |
| 53 | MP0000015_abnormal_ear_pigmentation | 1.29896625 |
| 54 | MP0002896_abnormal_bone_mineralization | 1.28307981 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.23200289 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.21894126 |
| 57 | MP0002254_reproductive_system_inflammat | 1.21388621 |
| 58 | MP0010030_abnormal_orbit_morphology | 1.20106506 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.19106198 |
| 60 | MP0000003_abnormal_adipose_tissue | 1.18812652 |
| 61 | MP0001186_pigmentation_phenotype | 1.18068874 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.17955049 |
| 63 | MP0004957_abnormal_blastocyst_morpholog | 1.16016147 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.12811950 |
| 65 | MP0001915_intracranial_hemorrhage | 1.10832722 |
| 66 | MP0002098_abnormal_vibrissa_morphology | 1.09719303 |
| 67 | MP0010771_integument_phenotype | 1.09242990 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.09015346 |
| 69 | MP0000627_abnormal_mammary_gland | 1.08323247 |
| 70 | MP0005165_increased_susceptibility_to | 1.08227996 |
| 71 | MP0001661_extended_life_span | 1.08020989 |
| 72 | MP0003186_abnormal_redox_activity | 1.07393763 |
| 73 | * MP0000733_abnormal_muscle_development | 1.06916593 |
| 74 | MP0005197_abnormal_uvea_morphology | 1.04722661 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.04621582 |
| 76 | MP0009643_abnormal_urine_homeostasis | 1.03046528 |
| 77 | MP0002102_abnormal_ear_morphology | 1.01018508 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.00747473 |
| 79 | MP0000749_muscle_degeneration | 1.00275543 |
| 80 | MP0002090_abnormal_vision | 0.93024542 |
| 81 | MP0009764_decreased_sensitivity_to | 0.92185953 |
| 82 | MP0000751_myopathy | 0.91809153 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.91172480 |
| 84 | MP0005621_abnormal_cell_physiology | 0.90884189 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.90704615 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.90682123 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.89667882 |
| 88 | * MP0002086_abnormal_extraembryonic_tissu | 0.87625004 |
| 89 | MP0009697_abnormal_copulation | 0.87399281 |
| 90 | MP0003868_abnormal_feces_composition | 0.84613303 |
| 91 | MP0005174_abnormal_tail_pigmentation | 0.83770245 |
| 92 | MP0002269_muscular_atrophy | 0.83761668 |
| 93 | MP0005193_abnormal_anterior_eye | 0.83510361 |
| 94 | MP0003011_delayed_dark_adaptation | 0.83241352 |
| 95 | MP0008932_abnormal_embryonic_tissue | 0.82996464 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82635206 |
| 97 | MP0000566_synostosis | 0.81914947 |
| 98 | MP0003436_decreased_susceptibility_to | 0.81769317 |
| 99 | MP0001730_embryonic_growth_arrest | 0.81650371 |
| 100 | MP0002697_abnormal_eye_size | 0.81469147 |
| 101 | MP0000858_altered_metastatic_potential | 0.81410550 |
| 102 | MP0006138_congestive_heart_failure | 0.80931781 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.78415862 |
| 104 | MP0008007_abnormal_cellular_replicative | 0.78350089 |
| 105 | MP0003111_abnormal_nucleus_morphology | 0.77891908 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.75638133 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.74963648 |
| 108 | MP0004087_abnormal_muscle_fiber | 0.74196322 |
| 109 | MP0001243_abnormal_dermal_layer | 0.73637821 |
| 110 | * MP0005164_abnormal_response_to | 0.73548895 |
| 111 | MP0004885_abnormal_endolymph | 0.72454675 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.72286161 |
| 113 | MP0003077_abnormal_cell_cycle | 0.71882300 |
| 114 | MP0000350_abnormal_cell_proliferation | 0.71841761 |
| 115 | * MP0000598_abnormal_liver_morphology | 0.71329415 |
| 116 | MP0003693_abnormal_embryo_hatching | 0.70250908 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.69211935 |
| 118 | MP0003984_embryonic_growth_retardation | 0.69075889 |
| 119 | MP0000647_abnormal_sebaceous_gland | 0.68590395 |
| 120 | MP0000432_abnormal_head_morphology | 0.68425406 |
| 121 | MP0006054_spinal_hemorrhage | 0.68386668 |
| 122 | MP0003755_abnormal_palate_morphology | 0.67587135 |
| 123 | MP0000604_amyloidosis | 0.67513826 |
| 124 | MP0002084_abnormal_developmental_patter | 0.66968372 |
| 125 | MP0003385_abnormal_body_wall | 0.66556630 |
| 126 | MP0004947_skin_inflammation | 0.66237564 |
| 127 | MP0000534_abnormal_ureter_morphology | 0.66177826 |
| 128 | MP0003115_abnormal_respiratory_system | 0.66167683 |
| 129 | MP0002234_abnormal_pharynx_morphology | 0.65532686 |
| 130 | MP0000367_abnormal_coat/_hair | 0.65482390 |
| 131 | MP0001958_emphysema | 0.65423647 |
| 132 | MP0003724_increased_susceptibility_to | 0.65087838 |
| 133 | MP0005636_abnormal_mineral_homeostasis | 0.63398250 |
| 134 | MP0005451_abnormal_body_composition | 0.62905826 |
| 135 | MP0003303_peritoneal_inflammation | 0.61063723 |
| 136 | MP0000377_abnormal_hair_follicle | 0.60898910 |
| 137 | MP0001756_abnormal_urination | 0.60548520 |
| 138 | MP0008469_abnormal_protein_level | 0.58295666 |
| 139 | MP0004130_abnormal_muscle_cell | 0.58219693 |
| 140 | MP0002796_impaired_skin_barrier | 0.57496733 |
| 141 | * MP0002136_abnormal_kidney_physiology | 0.55331176 |
| 142 | MP0009763_increased_sensitivity_to | 0.54768426 |
| 143 | MP0003091_abnormal_cell_migration | 0.54072521 |
| 144 | MP0002060_abnormal_skin_morphology | 0.53581773 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.52893221 |
| 146 | MP0002938_white_spotting | 0.52135088 |
| 147 | MP0002295_abnormal_pulmonary_circulatio | 0.51981736 |
| 148 | MP0005464_abnormal_platelet_physiology | 0.51712915 |
| 149 | MP0004185_abnormal_adipocyte_glucose | 0.51428035 |
| 150 | MP0005166_decreased_susceptibility_to | 0.49828901 |
| 151 | MP0009053_abnormal_anal_canal | 0.49359528 |
| 152 | * MP0005023_abnormal_wound_healing | 0.48745179 |
| 153 | MP0003075_altered_response_to | 0.48387518 |
| 154 | MP0002971_abnormal_brown_adipose | 0.48237163 |
| 155 | MP0002168_other_aberrant_phenotype | 0.47266482 |
| 156 | MP0005220_abnormal_exocrine_pancreas | 0.46477331 |
| 157 | MP0002419_abnormal_innate_immunity | 0.44405573 |
| 158 | MP0005334_abnormal_fat_pad | 0.44308328 |
| 159 | MP0009642_abnormal_blood_homeostasis | 0.43844032 |
| 160 | MP0005275_abnormal_skin_tensile | 0.43808096 |
| 161 | MP0003656_abnormal_erythrocyte_physiolo | 0.42055735 |
| 162 | MP0001764_abnormal_homeostasis | 0.41063994 |
| 163 | MP0005167_abnormal_blood-brain_barrier | 0.41042105 |
| 164 | MP0002998_abnormal_bone_remodeling | 0.40160660 |
| 165 | MP0006082_CNS_inflammation | 0.40020513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia/Hypoplasia of the macula (HP:0008059) | 6.28706806 |
| 2 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 5.87289381 |
| 3 | Blue irides (HP:0000635) | 5.86954436 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.24286569 |
| 5 | Hypoplasia of the fovea (HP:0007750) | 5.16054873 |
| 6 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 5.16054873 |
| 7 | Xanthomatosis (HP:0000991) | 4.95407298 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.94828858 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.46050785 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.43964632 |
| 11 | Atrophic scars (HP:0001075) | 4.33035855 |
| 12 | Ocular albinism (HP:0001107) | 4.21274282 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18603891 |
| 14 | Protrusio acetabuli (HP:0003179) | 4.15302800 |
| 15 | Abnormality of the fovea (HP:0000493) | 4.10348000 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.05967439 |
| 17 | Premature rupture of membranes (HP:0001788) | 3.96434093 |
| 18 | Short nail (HP:0001799) | 3.91203415 |
| 19 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.88164509 |
| 20 | Osteolytic defects of the hand bones (HP:0009699) | 3.88164509 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.82748984 |
| 22 | Milia (HP:0001056) | 3.80799981 |
| 23 | Hypopigmentation of the fundus (HP:0007894) | 3.71358338 |
| 24 | Complement deficiency (HP:0004431) | 3.65397008 |
| 25 | Epidermoid cyst (HP:0200040) | 3.52792809 |
| 26 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.50067571 |
| 27 | Joint hemorrhage (HP:0005261) | 3.48195644 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.47187403 |
| 29 | Generalized hypopigmentation (HP:0007513) | 3.46795605 |
| 30 | Onycholysis (HP:0001806) | 3.46250323 |
| 31 | Iris hypopigmentation (HP:0007730) | 3.45493725 |
| 32 | Vertebral compression fractures (HP:0002953) | 3.44734973 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 3.38738191 |
| 34 | Hypolipoproteinemia (HP:0010981) | 3.33503850 |
| 35 | Fragile skin (HP:0001030) | 3.28836436 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.28551333 |
| 37 | Right ventricular cardiomyopathy (HP:0011663) | 3.24318793 |
| 38 | Arterial tortuosity (HP:0005116) | 3.23997587 |
| 39 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.17083279 |
| 40 | Spastic diplegia (HP:0001264) | 3.10774340 |
| 41 | Abnormality of proline metabolism (HP:0010907) | 3.08191409 |
| 42 | Hydroxyprolinuria (HP:0003080) | 3.08191409 |
| 43 | Selective tooth agenesis (HP:0001592) | 3.06398763 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.01601372 |
| 45 | Broad face (HP:0000283) | 3.01187610 |
| 46 | Congenital sensorineural hearing impairment (HP:0008527) | 3.00958675 |
| 47 | Fragile nails (HP:0001808) | 2.96534668 |
| 48 | Ketosis (HP:0001946) | 2.96427818 |
| 49 | Hyperammonemia (HP:0001987) | 2.93872477 |
| 50 | Abnormality of complement system (HP:0005339) | 2.91726916 |
| 51 | White forelock (HP:0002211) | 2.91521166 |
| 52 | Increased connective tissue (HP:0009025) | 2.90929523 |
| 53 | Myocardial infarction (HP:0001658) | 2.89419780 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.87508173 |
| 55 | Vascular tortuosity (HP:0004948) | 2.87434212 |
| 56 | Esophageal varix (HP:0002040) | 2.83336997 |
| 57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.82656722 |
| 58 | Plantar hyperkeratosis (HP:0007556) | 2.82137456 |
| 59 | Fat malabsorption (HP:0002630) | 2.78221852 |
| 60 | * Hepatocellular carcinoma (HP:0001402) | 2.77537992 |
| 61 | Gout (HP:0001997) | 2.76533954 |
| 62 | Ulnar bowing (HP:0003031) | 2.76117250 |
| 63 | Alopecia of scalp (HP:0002293) | 2.73535968 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73458107 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.73416786 |
| 66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.73205575 |
| 67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.72922879 |
| 68 | Hypoplasia of the iris (HP:0007676) | 2.71878490 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.71862964 |
| 70 | Hyperglycinuria (HP:0003108) | 2.69714504 |
| 71 | Thick nail (HP:0001805) | 2.68356741 |
| 72 | Ankyloglossia (HP:0010296) | 2.67765882 |
| 73 | Cutaneous melanoma (HP:0012056) | 2.65025376 |
| 74 | Natal tooth (HP:0000695) | 2.63712237 |
| 75 | Pterygium (HP:0001059) | 2.62717258 |
| 76 | Abnormality of oral frenula (HP:0000190) | 2.61406372 |
| 77 | Nail dystrophy (HP:0008404) | 2.61311573 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.60747826 |
| 79 | Ketoacidosis (HP:0001993) | 2.59295513 |
| 80 | Hyperacusis (HP:0010780) | 2.58220724 |
| 81 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.57767991 |
| 82 | Abnormality of glycine metabolism (HP:0010895) | 2.57767991 |
| 83 | Cervical subluxation (HP:0003308) | 2.57563698 |
| 84 | Patchy hypopigmentation of hair (HP:0011365) | 2.54290124 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.53630929 |
| 86 | Wormian bones (HP:0002645) | 2.49774300 |
| 87 | Hypoglycemic coma (HP:0001325) | 2.48568763 |
| 88 | Ridged nail (HP:0001807) | 2.46635094 |
| 89 | Hyperglycinemia (HP:0002154) | 2.45392002 |
| 90 | Glucose intolerance (HP:0000833) | 2.44637724 |
| 91 | Focal segmental glomerulosclerosis (HP:0000097) | 2.44530180 |
| 92 | Abnormality of nucleobase metabolism (HP:0010932) | 2.43984714 |
| 93 | Generalized hypopigmentation of hair (HP:0011358) | 2.42275785 |
| 94 | Trismus (HP:0000211) | 2.40526403 |
| 95 | Abnormality of methionine metabolism (HP:0010901) | 2.34864526 |
| 96 | Flat acetabular roof (HP:0003180) | 2.29090813 |
| 97 | Elbow flexion contracture (HP:0002987) | 2.29009773 |
| 98 | Vascular calcification (HP:0004934) | 2.27847719 |
| 99 | Skin nodule (HP:0200036) | 2.27340843 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25922414 |
| 101 | Mucopolysacchariduria (HP:0008155) | 2.25922414 |
| 102 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25873221 |
| 103 | Spinal rigidity (HP:0003306) | 2.24464830 |
| 104 | Aortic dissection (HP:0002647) | 2.20010513 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 2.17383531 |
| 106 | Cholecystitis (HP:0001082) | 2.17383531 |
| 107 | Achilles tendon contracture (HP:0001771) | 2.17322894 |
| 108 | Entropion (HP:0000621) | 2.17235924 |
| 109 | Deviation of the thumb (HP:0009603) | 2.16693916 |
| 110 | Cardiovascular calcification (HP:0011915) | 2.11515725 |
| 111 | Distal upper limb amyotrophy (HP:0007149) | 2.11114740 |
| 112 | Upper limb amyotrophy (HP:0009129) | 2.11114740 |
| 113 | Abnormality of carpal bone ossification (HP:0006257) | 2.10901465 |
| 114 | Abnormality of the Achilles tendon (HP:0005109) | 2.10803538 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 2.10643849 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10458489 |
| 117 | Hypoplasia of dental enamel (HP:0006297) | 2.09295319 |
| 118 | Glomerulosclerosis (HP:0000096) | 2.07872045 |
| 119 | Advanced eruption of teeth (HP:0006288) | 2.05640303 |
| 120 | Abnormality of the acetabulum (HP:0003170) | 2.05543931 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 2.05396193 |
| 122 | Ankle contracture (HP:0006466) | 2.04559917 |
| 123 | Pili torti (HP:0003777) | 2.04552775 |
| 124 | Distal lower limb muscle weakness (HP:0009053) | 2.04310291 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.03596234 |
| 126 | Lower limb amyotrophy (HP:0007210) | 2.03336294 |
| 127 | Spinal cord compression (HP:0002176) | 2.03281262 |
| 128 | Aortic aneurysm (HP:0004942) | 2.03149885 |
| 129 | Insomnia (HP:0100785) | 2.02490552 |
| 130 | Conjugated hyperbilirubinemia (HP:0002908) | 2.01487952 |
| 131 | Nephritis (HP:0000123) | 2.01217216 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99238340 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99238340 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99238340 |
| 135 | Aplasia cutis congenita (HP:0001057) | 1.99009564 |
| 136 | Steatorrhea (HP:0002570) | 1.98695561 |
| 137 | Abnormal ossification of hand bones (HP:0005921) | 1.98002301 |
| 138 | Spondylolisthesis (HP:0003302) | 1.94331733 |
| 139 | Glomerulonephritis (HP:0000099) | 1.94105158 |
| 140 | Abnormal hair laboratory examination (HP:0003328) | 1.89665724 |
| 141 | Abnormality of the gastric mucosa (HP:0004295) | 1.89606907 |
| 142 | Vertebral arch anomaly (HP:0008438) | 1.88847515 |
| 143 | Hyperuricemia (HP:0002149) | 1.88189459 |
| 144 | Increased purine levels (HP:0004368) | 1.88189459 |
| 145 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.87082440 |
| 146 | Amyloidosis (HP:0011034) | 1.86440637 |
| 147 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.86192016 |
| 148 | Mitral stenosis (HP:0001718) | 1.84574891 |
| 149 | Palmoplantar hyperkeratosis (HP:0000972) | 1.83408992 |
| 150 | Hemorrhage of the eye (HP:0011885) | 1.81378194 |
| 151 | Tibial bowing (HP:0002982) | 1.80869435 |
| 152 | Sparse eyelashes (HP:0000653) | 1.80017299 |
| 153 | Bowing of the arm (HP:0006488) | 1.79636260 |
| 154 | Bowed forearm bones (HP:0003956) | 1.79636260 |
| 155 | Syringomyelia (HP:0003396) | 1.79577090 |
| 156 | Spinal cord lesions (HP:0100561) | 1.79577090 |
| 157 | Insidious onset (HP:0003587) | 1.79497300 |
| 158 | Termporal pattern (HP:0011008) | 1.79497300 |
| 159 | Difficulty climbing stairs (HP:0003551) | 1.79415095 |
| 160 | Absent frontal sinuses (HP:0002688) | 1.77482508 |
| 161 | Gingival bleeding (HP:0000225) | 1.77306336 |
| 162 | Hyperbilirubinemia (HP:0002904) | 1.77294066 |
| 163 | Menorrhagia (HP:0000132) | 1.75333721 |
| 164 | Cerebral aneurysm (HP:0004944) | 1.73735533 |
| 165 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73426529 |
| 166 | Palmar hyperkeratosis (HP:0010765) | 1.72862556 |
| 167 | Tetraparesis (HP:0002273) | 1.72552648 |
| 168 | Proximal placement of thumb (HP:0009623) | 1.71662404 |
| 169 | Freckling (HP:0001480) | 1.71252960 |
| 170 | Coxa vara (HP:0002812) | 1.70965086 |
| 171 | Albinism (HP:0001022) | 1.70376953 |
| 172 | Abnormality of iron homeostasis (HP:0011031) | 1.70153780 |
| 173 | Cerebral inclusion bodies (HP:0100314) | 1.69772461 |
| 174 | Increased mean platelet volume (HP:0011877) | 1.69410903 |
| 175 | Abnormality of vision evoked potentials (HP:0000649) | 1.69215524 |
| 176 | Abnormal glucose tolerance (HP:0001952) | 1.68134940 |
| 177 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.68112856 |
| 178 | Delayed CNS myelination (HP:0002188) | 1.68084394 |
| 179 | Proximal tubulopathy (HP:0000114) | 1.67720133 |
| 180 | Shallow orbits (HP:0000586) | 1.67534088 |
| 181 | Long toe (HP:0010511) | 1.67351406 |
| 182 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.67240106 |
| 183 | Spontaneous abortion (HP:0005268) | 1.67129431 |
| 184 | Metabolic acidosis (HP:0001942) | 1.65811012 |
| 185 | Abnormal blistering of the skin (HP:0008066) | 1.65304660 |
| 186 | Acanthosis nigricans (HP:0000956) | 1.64923142 |
| 187 | Periodontitis (HP:0000704) | 1.64756912 |
| 188 | Poikiloderma (HP:0001029) | 1.64740557 |
| 189 | Abnormality of the nasal septum (HP:0000419) | 1.61525077 |
| 190 | Mitral regurgitation (HP:0001653) | 1.61087215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MST1R | 6.45846545 |
| 2 | PKN2 | 4.21283518 |
| 3 | TRIB3 | 3.89806831 |
| 4 | LATS1 | 3.28779645 |
| 5 | MARK3 | 3.27118758 |
| 6 | FGFR4 | 2.88654269 |
| 7 | SIK1 | 2.72683721 |
| 8 | ERN1 | 2.68658539 |
| 9 | EPHA3 | 2.59494919 |
| 10 | FRK | 2.55030201 |
| 11 | PTK6 | 2.21523600 |
| 12 | BCKDK | 2.19386112 |
| 13 | PBK | 2.06356580 |
| 14 | EPHA2 | 2.04694212 |
| 15 | ERBB4 | 2.02480251 |
| 16 | RIPK1 | 1.98149982 |
| 17 | TBK1 | 1.89479795 |
| 18 | TTN | 1.78204669 |
| 19 | ICK | 1.68259937 |
| 20 | EIF2AK1 | 1.68167398 |
| 21 | DDR2 | 1.65195584 |
| 22 | NEK9 | 1.62903906 |
| 23 | SCYL2 | 1.61325048 |
| 24 | LRRK2 | 1.56931344 |
| 25 | GSK3A | 1.39656400 |
| 26 | MAP3K14 | 1.37455959 |
| 27 | CDK8 | 1.34237338 |
| 28 | TYK2 | 1.33756525 |
| 29 | ABL2 | 1.31283995 |
| 30 | FER | 1.30216277 |
| 31 | TAOK3 | 1.29518696 |
| 32 | FLT3 | 1.28537227 |
| 33 | STK39 | 1.27679233 |
| 34 | MAP3K12 | 1.27165672 |
| 35 | EPHB1 | 1.25632936 |
| 36 | NTRK1 | 1.24725623 |
| 37 | JAK1 | 1.16595646 |
| 38 | BUB1 | 1.14900508 |
| 39 | NEK1 | 1.14393039 |
| 40 | CAMK1D | 1.13131128 |
| 41 | CDK6 | 1.12950015 |
| 42 | CDK12 | 1.10041975 |
| 43 | STK3 | 1.08704651 |
| 44 | PTK2 | 1.06233057 |
| 45 | TESK1 | 1.04874889 |
| 46 | PDGFRA | 1.03969970 |
| 47 | MAP3K2 | 1.03348783 |
| 48 | LIMK1 | 0.99372512 |
| 49 | MAP3K9 | 0.98577445 |
| 50 | MAP3K3 | 0.98155380 |
| 51 | FGFR3 | 0.97758075 |
| 52 | WNK4 | 0.97328916 |
| 53 | JAK2 | 0.96977225 |
| 54 | EIF2AK3 | 0.96622622 |
| 55 | STK38L | 0.95411251 |
| 56 | TRPM7 | 0.91666972 |
| 57 | FGFR2 | 0.90910167 |
| 58 | MELK | 0.89445546 |
| 59 | INSRR | 0.88606399 |
| 60 | BRSK2 | 0.85793080 |
| 61 | STK38 | 0.84699651 |
| 62 | JAK3 | 0.82112774 |
| 63 | EEF2K | 0.81676994 |
| 64 | RET | 0.80703569 |
| 65 | MYLK | 0.80668616 |
| 66 | ERBB2 | 0.79528140 |
| 67 | MAP3K10 | 0.79182891 |
| 68 | TTK | 0.78702125 |
| 69 | MAPK11 | 0.75784977 |
| 70 | BRSK1 | 0.75480758 |
| 71 | * BMX | 0.75412060 |
| 72 | NUAK1 | 0.75236269 |
| 73 | PDGFRB | 0.72652183 |
| 74 | CSK | 0.72471691 |
| 75 | MST4 | 0.71347161 |
| 76 | TSSK6 | 0.70876300 |
| 77 | NME2 | 0.68902520 |
| 78 | SMG1 | 0.68661311 |
| 79 | MAP3K11 | 0.67478658 |
| 80 | PDK2 | 0.66588233 |
| 81 | ARAF | 0.65440574 |
| 82 | PRKG2 | 0.65316495 |
| 83 | CHUK | 0.64986157 |
| 84 | MAP2K1 | 0.64031494 |
| 85 | BCR | 0.63131145 |
| 86 | EGFR | 0.61734327 |
| 87 | PAK4 | 0.61307777 |
| 88 | EPHB2 | 0.60764084 |
| 89 | CSNK1G1 | 0.60516325 |
| 90 | LATS2 | 0.60303102 |
| 91 | RPS6KA4 | 0.60094162 |
| 92 | AURKB | 0.59927853 |
| 93 | TGFBR2 | 0.59819181 |
| 94 | WEE1 | 0.59247891 |
| 95 | MAP2K3 | 0.57493010 |
| 96 | MAP3K1 | 0.56339603 |
| 97 | PIK3CG | 0.55860236 |
| 98 | ERBB3 | 0.55800605 |
| 99 | DAPK2 | 0.55516906 |
| 100 | KSR2 | 0.54554631 |
| 101 | PHKG2 | 0.54494846 |
| 102 | PHKG1 | 0.54494846 |
| 103 | PRKCI | 0.54356265 |
| 104 | PDPK1 | 0.53945503 |
| 105 | CAMKK1 | 0.53761229 |
| 106 | SIK3 | 0.53183101 |
| 107 | IRAK3 | 0.53173054 |
| 108 | CSNK1A1L | 0.51411933 |
| 109 | WNK3 | 0.51330456 |
| 110 | STK10 | 0.50285389 |
| 111 | NEK2 | 0.49991290 |
| 112 | PRKAA2 | 0.49648532 |
| 113 | PIK3CA | 0.49339068 |
| 114 | STK24 | 0.49211353 |
| 115 | MAP3K8 | 0.47611940 |
| 116 | DYRK1B | 0.47156164 |
| 117 | LMTK2 | 0.47142196 |
| 118 | IKBKE | 0.46541623 |
| 119 | SGK3 | 0.45744370 |
| 120 | AKT2 | 0.44756437 |
| 121 | RPS6KB2 | 0.44527641 |
| 122 | RIPK4 | 0.43596814 |
| 123 | BLK | 0.43500727 |
| 124 | MOS | 0.43217658 |
| 125 | EIF2AK2 | 0.42827087 |
| 126 | MTOR | 0.42404954 |
| 127 | FGFR1 | 0.41061819 |
| 128 | * ABL1 | 0.39465710 |
| 129 | PAK2 | 0.38809040 |
| 130 | CAMK2G | 0.38149103 |
| 131 | PIM2 | 0.37357238 |
| 132 | ILK | 0.37203718 |
| 133 | CDK9 | 0.35185932 |
| 134 | RPS6KA1 | 0.34761554 |
| 135 | CDK7 | 0.34591532 |
| 136 | BRAF | 0.34510421 |
| 137 | PAK3 | 0.34469646 |
| 138 | CSNK1G2 | 0.34208674 |
| 139 | * MET | 0.33936899 |
| 140 | CAMK1G | 0.33564380 |
| 141 | MAP2K4 | 0.33161227 |
| 142 | MAP3K5 | 0.32290708 |
| 143 | ROCK2 | 0.32247082 |
| 144 | KSR1 | 0.31965458 |
| 145 | PLK1 | 0.31608519 |
| 146 | NEK6 | 0.31381145 |
| 147 | AKT3 | 0.30387331 |
| 148 | AURKA | 0.29432852 |
| 149 | MAPKAPK3 | 0.28704510 |
| 150 | IRAK2 | 0.23867452 |
| 151 | BMPR2 | 0.23500621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.66859373 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17661101 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12858155 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.10969995 |
| 5 | Tyrosine metabolism_Homo sapiens_hsa00350 | 3.09259669 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64184983 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57069219 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53477849 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34908265 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31011672 |
| 11 | * Focal adhesion_Homo sapiens_hsa04510 | 2.20917771 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16545479 |
| 13 | * Adherens junction_Homo sapiens_hsa04520 | 2.16477633 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.15597708 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.13181255 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09396690 |
| 17 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.07926738 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96746954 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96477999 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87369767 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86792920 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83469412 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.77907583 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74191993 |
| 25 | Thyroid cancer_Homo sapiens_hsa05216 | 1.73396517 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71913970 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69054615 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69019139 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64017556 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63702945 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.62501582 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59982365 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58352845 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57050529 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56921463 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.55409046 |
| 37 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.50403990 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43921429 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43904830 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43566350 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.42685626 |
| 42 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.41684625 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38738362 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36093074 |
| 45 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.35333723 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.29807111 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27846903 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26498027 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20924236 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19965471 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19297312 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18707467 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18592023 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18398642 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17400416 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15629749 |
| 57 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.14946737 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09332839 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08034571 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07008326 |
| 61 | Cell cycle_Homo sapiens_hsa04110 | 1.05950408 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05260021 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04206460 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.99910579 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98670394 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.98542695 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97187629 |
| 68 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96098576 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95297486 |
| 70 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.95000190 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.92043741 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91302032 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.88798033 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87600301 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85137370 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82675388 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82568006 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81102806 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80705608 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.79300885 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77769013 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77087421 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76797737 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75996153 |
| 85 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.74391451 |
| 86 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.73616341 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72427443 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71087947 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70940260 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70759239 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69469829 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68508970 |
| 93 | DNA replication_Homo sapiens_hsa03030 | 0.68193766 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67962588 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.65548489 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65213123 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64714595 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64341645 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63627700 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62718277 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62129346 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.61271774 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60468244 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59810899 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.58470558 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57363826 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57197179 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55596622 |
| 109 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55508112 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55494028 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.55189977 |
| 112 | Glioma_Homo sapiens_hsa05214 | 0.54265447 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54085923 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53229061 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.52276703 |
| 116 | Proteasome_Homo sapiens_hsa03050 | 0.51060679 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.50413008 |
| 118 | * Endocytosis_Homo sapiens_hsa04144 | 0.49144164 |
| 119 | RNA transport_Homo sapiens_hsa03013 | 0.48853854 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47752539 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.46716902 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46178850 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44443284 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43153649 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42913165 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40253667 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.39978939 |
| 128 | Legionellosis_Homo sapiens_hsa05134 | 0.37675350 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.35866602 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35114180 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.33660342 |
| 132 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28958635 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.28244836 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27429253 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25868322 |
| 136 | Melanogenesis_Homo sapiens_hsa04916 | 0.25438733 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.23928989 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22990305 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22839910 |
| 140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20884348 |
| 141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.18781281 |
| 142 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18764296 |
| 143 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18340640 |
| 144 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17453529 |
| 145 | Tuberculosis_Homo sapiens_hsa05152 | 0.16275048 |
| 146 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16038201 |
| 147 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15167676 |
| 148 | Bladder cancer_Homo sapiens_hsa05219 | 0.14054759 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14034969 |
| 150 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13142974 |
| 151 | * Malaria_Homo sapiens_hsa05144 | 0.13036536 |
| 152 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12796590 |
| 153 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.12408374 |
| 154 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12109195 |

